Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Buying the Best Top-Ranked Stocks in December
Buying the Best Top-Ranked Stocks in December

The stock market bulls dove back into hard-hit stocks in the final week of November following the first significant pullback in few months. Buyers stepped up again on Tuesday after a pullback on the

The 3 Best Magnificent 7 Stocks for 2026 (GOOGL, AAPL, TSLA)
The 3 Best Magnificent 7 Stocks for 2026 (GOOGL, AAPL, TSLA)

Last month’s volatility brought a bit more than a 5% decline in the major indices, but the real damage occurred beneath the surface, where speculative pockets of the market corrected sharply. For

Best Risk-Adjusted AI Portfolio for 2026: NVIDIA & PalantirPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
Best Risk-Adjusted AI Portfolio for 2026: NVIDIA & Palantir

As we approach 2026, investors might be wondering how to capitalize on the next artificial intelligence (AI) boom. The best strategy is to invest in both NVIDIA Corporation NVDA and Palantir

Why Policy Goals Will Make 2026 a Breakout Year for IONQ, RGTI, QBTSPhoto, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Why Policy Goals Will Make 2026 a Breakout Year for IONQ, RGTI, QBTS

Since the original National Quantum Initiative (NQI) Act in 2018, quantum has been treated as a strategic technology alongside AI and advanced semiconductors. The FY 2025 NQI budget supplement shows

REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATDPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD

Regeneron Pharmaceuticals, Inc. REGN announced a collaboration agreement with private company Tessera Therapeutics, Inc. for the latter’s TSRA-196.

Both companies will jointly develop Tessera’s lead

BP Abandons H2Teesside Carbon Capture & Hydrogen Scheme Amid AI PushPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
BP Abandons H2Teesside Carbon Capture & Hydrogen Scheme Amid AI Push

BP plc BP, an oil and gas giant, has scrapped plans for the construction of a large hydrogen and carbon capture project at Teesside in north-east England. Per the Financial Times, the company moved

BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution BusinessPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business

Shares of Bausch Health, Inc. BHC have gained 11% after the company announced the acquisition of Wuhan Shibo Zhenmei Technology Co., Ltd.

Bausch Health’s aesthetics business, Solta Medical, acquired

Wabtec Completes Frauscher Sensor Technology Group Acquisition
Wabtec Completes Frauscher Sensor Technology Group Acquisition

Wabtec Corporation (WAB) announced that it has completed the acquisition of Frauscher Sensor Technology Group GmbH (Frauscher) for an enterprise value of €675 million in cash.  The purchase price

Goldman to Expand ETF Footprint With the Buyout of Innovator Capital
Goldman to Expand ETF Footprint With the Buyout of Innovator Capital

The Goldman Sachs Group, Inc. GS has entered into an agreement to acquire Innovator Capital Management (Innovator), a leading provider of defined outcome exchange-traded funds (ETFs). Innovator

Marsh & McLennan Unit Expands in Hawai'i With Three Brokerage BuysPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Marsh & McLennan Unit Expands in Hawai'i With Three Brokerage Buys

Marsh & McLennan Companies, Inc.’s MMC Marsh McLennan Agency (“MMA”), a division of MMC’s Marsh business, recently purchased three privately held insurance brokerages based in Honolulu, Hawai‘i. The

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

Ecolab Inc. ECL has been gaining from its solid product portfolio. The optimism, led by a solid third-quarter 2025 performance and continued focus on research and development, is expected to

AT&T Stock Declines 7.8% in Six Months: Should You Buy in the Dip?
AT&T Stock Declines 7.8% in Six Months: Should You Buy in the Dip?

AT&T, Inc. T has declined 7.8% over the past six months compared to the Wireless National industry’s decline of 10%. The stock has underperformed compared to the Zacks Computer & Technology sector

GEHC Unveils Allia Moveo to Elevate Mobility in Interventional CarePhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
GEHC Unveils Allia Moveo to Elevate Mobility in Interventional Care

GE HealthCare GEHC recently unveiled Allia Moveo, a next-generation interventional imaging platform built to enhance mobility, access and workflow. Its compact, cable-free, wide-bore C-arm is

Vertiv Surges 57% in the Past 6 Months: Is the Stock Worth Buying?
Vertiv Surges 57% in the Past 6 Months: Is the Stock Worth Buying?

Vertiv VRT shares have gained 59.6% in the past six months, outperforming the broader Zacks Computer and Technology sector’s increase of 27.2%. The Zacks Computers - IT Services industry declined

Is Oceaneering International (OII) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Oceaneering International (OII) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

3 Reasons Growth Investors Will Love Hennes & Mauritz (HNNMY)
3 Reasons Growth Investors Will Love Hennes & Mauritz (HNNMY)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Should You Buy, Sell, or Hold Rubrik Stock Before Q3 Earnings Release?
Should You Buy, Sell, or Hold Rubrik Stock Before Q3 Earnings Release?

Rubrik RBRK is scheduled to release third-quarter fiscal 2026 results on Dec. 4.For the to-be-reported quarter, RBRK expects revenues between $319 million and $321 million, reflecting a

MKC's Q3 Shows Solid Consumer Momentum: Will the Strength Last in 2026?
MKC's Q3 Shows Solid Consumer Momentum: Will the Strength Last in 2026?

McCormick & Company, Inc. MKC experienced solid consumer momentum, primarily driven by volume-led growth. Particularly in the consumer segment, organic sales grew 3%, driven by volume growth across

4 Accident & Health Insurers to Watch Amid Rising Medical CostsPhoto, wide shot, wide-angle lens, soft focus,  Underwriting company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-N0Y6W7kvQQgUHnb7hSHO9TTV.png?st=2024-05-14T11%3A36%3A30Z&se=2024-05-14T13%3A36%3A30Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2024-05-13T19%3A10%3A46Z&ske=2024-05-14T19%3A10%3A46Z&sks=b&skv=2021-08-06&sig=1qvKLOloU0OWrpqzcuH7YcgBv7QI0hAOq2gAtJGiGqs%3D
4 Accident & Health Insurers to Watch Amid Rising Medical Costs
The Zacks Accident and Health Insurance industry is expected to benefit from an increase in underwriting exposure. Aflac Incorporated AFL, Unum Group UNM, Globe Life. GL and Trupanion TRUP are
Lyft's Customer-Friendly Deals to Boost Revenues: More Upside Ahead?
Lyft's Customer-Friendly Deals to Boost Revenues: More Upside Ahead?

Lyft LYFT has been rolling out customer-friendly offers and value-driven ride options to boost rides and its revenue stream. These moves are designed to spur higher ride frequency, re-engage

LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website

Eli Lilly LLY announced that it has lowered the price of single-dose vials of its blockbuster obesity drug, Zepbound (tirzepatide), purchased through the direct-to-consumer (DTC) platform

Can Bowhead Specialty Holdings Inc. (BOW) Run Higher on Rising Earnings Estimates?
Can Bowhead Specialty Holdings Inc. (BOW) Run Higher on Rising Earnings Estimates?

Bowhead Specialty Holdings Inc. (BOW) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend

Earnings Estimates Rising for IHS Holding (IHS): Will It Gain?
Earnings Estimates Rising for IHS Holding (IHS): Will It Gain?

IHS Holding (IHS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

Surging Earnings Estimates Signal Upside for Kohl's (KSS) Stock
Surging Earnings Estimates Signal Upside for Kohl's (KSS) Stock

Kohl's (KSS) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since

Can Affirm's Low-Ticket Purchases Outgrow Its Big-Ticket Categories?
Can Affirm's Low-Ticket Purchases Outgrow Its Big-Ticket Categories?

Affirm Holdings, Inc. AFRM is redefining its growth story by focusing on smaller, everyday purchases that used to be on the sidelines of its business. Traditionally known for financing big-ticket